Small pox was one of the most feared diseases until it became extinct not too long ago. Most of the Native Americans died of diseases. As you know, many Natives had many diseases, and the effects were really deadly. So deadly, that around 4,000 Native Americans died from diseases. The kids and young adults were worried most of all.
A $2.30 a share price would value Medibank at $6.3 billion, but the Government would actually receive less than this depending on how many shares went to retail investors on the $2 capped price.Topics: company-news, insurance, privatisation-and-deregulation, australia. $2.30 a share price would value Medibank at $6.3 billion, but the Government would actually receive less than this depending on how many shares went to retail investors on the $2 capped price. Topics: company-news, insurance, privatisation-and-deregulation, australia.
Johnson & Johnson (JNJ) and Zimmer Biomet (ZBH) are medtech stocks to own going into earnings season, but several others could be put on buy lists on pullbacks, an analyst says. RBC analyst Glenn Novarro said Wednesday that among large-cap medtech stocks, Johnson and Zimmer offer the best risk/reward into the first-quarter earnings season.